Kauppalehti

Scanfil plc: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market Act

Scanfil plc has received a notification from Reijo Pöllä on 20 October 2026 pursuant to Chapter 9, Section 10 of the Securities Market Act. Reijo Pöllä’s share of Scanfil plc’s shares and voting ...
Kauppalehti

Revenio Group Corporation: Notification of change in holdings according to Chapter 9, Section 10 of the Finnish Securities Market Act

Revenio Group Corporation has received the following notification pursuant to Chapter 9, section 5 of the Securities Markets Act (”SMA”), according to which William Demant Invest A/S voting rights in ...
Kauppalehti

Change in the Inderes Management Team: Change in CFO position

Mikko Wartiovaara, CFO and member of the Management Team of Inderes, has resigned to assume the role of CFO at Finnish Industry Investment Ltd (Tesi). He will step down from his position on December ...
Kauppalehti

Ponsse's interim report for 1 January - 30 September 2026

Low levels of construction and private consumption continued to affect demand in the forest industry, and consequently impacted Ponsse's customers. Among our market areas, the Nordic countries and ...
Kauppalehti

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (16.10.2026)

Kesko Corporation has on 19 October 2026 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. BlackRock, Inc.'s holding in Kesko ...
Kauppalehti

AACSB Deans Survey Finds AI and Finances Are Top of Mind

Global 2026–27 Deans Survey of 558 leaders identifies artificial intelligence as the clearest professional development ...
Kauppalehti

Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that six studies involving its genomic tests will be presented at the European Society for Medical Oncology (ESMO) ...
Kauppalehti

XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer

Investigator-sponsored study funded by the French National Cancer Institute (INCa) meets pre-specified primary efficacy success criterion with 61.3% 12-month overall survival. Exploratory Subgroup ...
Kauppalehti

Changes in UPM's Group Executive Team: Aki Temmes appointed Chief Financial Officer of UPM and Petri Hakanen Executive Vice President, UPM Fibres

Changes in UPM's Group Executive Team: Aki Temmes appointed Chief Financial Officer of UPM and Petri Hakanen Executive Vice President, UPM Fibres ...
Kauppalehti

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week

Two oral presentations to highlight new 76-week data showing sustained proteinuria reduction and continued eGFR stabilization with a consistent long-term safety profile; Additiona ...
Kauppalehti

Facephi makes the leap from identity verification to continuous protection against digital fraud with its new platform

The launch of Facephi Intelligence Platform responds to a scenario in which an identity may have been successfully verified and, even so, a third party can take over an account and operate later, even ...
Kauppalehti

Brian Kesseler Named CEO of TekniPlex

Veteran industrial leader and former Tenneco CEO to lead global materials science company. Wayne, PA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- TekniPlex, a global leader in materials science serving ...